# US 2002/0058795 A1 · Hydrophobic glycosylamine derivatives, compositions, and methods for use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0058795 A1
- Document ID: US20020058795A1
- Status: Published application
- Kind: A1
- Application number: 09/149,721
- Filed: 1998-09-08
- Published: 2002-05-16
- Earliest claimed: 1997-09-08
- Inventors: RUSS J. MUMPER; FRANK TAGLIAFERRI
- Web page: https://patentgrep.com/patent/US20020058795A1

## CPC

- C12N 15/87: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- A61K 47/549: {Sugars, nucleosides, nucleotides or nucleic acids}
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61P 35/00: Antineoplastic agents
- C07H 5/04: to nitrogen
- C07H 15/12: attached to a nitrogen atom of the saccharide radical
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

The invention relates in part to hydrophobic glycosylamine derivatives, methods for synthesizing hydrophobic derivatives, compositions comprising these derivatives, and methods for delivering macromolecules to cells by administering these compositions.

## Claims

### Claim 1

A compound comprising a glycosyl moiety having a nitrogen-based substituent linked to a carbon atom within said glycosyl moiety,
wherein said nitrogen-based substituent is selected from the group consisting of —NH2, —N+(CH3)3, —(CH2)n—N (R10)3, and —NH—C (N+H2) —NH2, and
wherein substituents linked to other carbon atoms within said glycosyl moiety are independently selected from the group consisting of hydrogen, -alkyl, —O— alkyl, —O—C (O) -alkyl, —O—CH2—CH2 (O—C (O) —R6) —CH2 (O—C (O) —R7), —O—CH2—CH2 (OR6) —CH2 (OR7) , —CH2—CH2 (R6) —CH2(R7) , —O—(CH2)m-cholesterol, polyethylene glycol, —O—(CH2)n—N (R8)3, —NH2, —N+(CH3)3, —(CH2)n—N (R9)3, and —(CH2)—OR10,
wherein R6, R7, R8, R9, and R10 are independently selected from the group consisting of hydrogen, methyl, and alkyl,
wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and
wherein n is selected from the group consisting of 1, 2, 3, 4, and 5.

### Claim 2 (depends on 1)

A compound of claim 1 having a structure set forth in formula I:
14
wherein said R1 and R1′ are independently selected from the group consisting of hydrogen, —OH, —OCH3, -alkyl, —O— alkyl, —O—C(O)-alkyl, —O—CH2—CH2 (O—C (O) —R6) —CH2 (O—C (O) —R7) , —O—CH2—CH2 (OR6) —CH2 (OR7) , —O—CH2—CH2 (R6) —CH2 (R7) , —O—(CH2)m-cholesterol, polyethylene glycol, —O—(CH2)m—N (R8)3, —NH2, —N+(CH3)3, —(CH2)n—N (R9)3, and —(CH2)—OR10, wherein R6, R7, R8, R9, and R10 are independently selected from the group consisting of hydrogen, methyl, and alkyl, and wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5;
wherein R2 and R2′ are independently selected from the group consisting of hydrogen, —NH2, —N+(CH3)3, —(CH2)n—N (R1)3, and —NH—C (N+H2) —NH2, wherein said R11 is selected from the group consisting of hydrogen, methyl, and alkyl; and
wherein R3, R3′, R4, R4′, R5 and R5′ are independently selected from the group consisting of hydrogen, —OH, —OCH3, -alkyl, —O— alkyl, —O—C(O)-alkyl, —O—CH2—CH2 (O—C (O) —R6) —CH2 (O—C (O) —R7), —O—CH2—CH2 (OR6) —CH2 (OR7) , —O—CH2—CH2(R6) —CH2 (R7) —O—(CH2)m-cholesterol, polyethylene glycol, —O—(CH2)n—N (R8)3, —NH2, —N+(CH3)3, —(CH2)—N (R9)3, and —(CH2)—OR10 wherein R6, R7, R8, R9, and Rlo are independently selected from the group consisting of hydrogen, methyl, and alkyl, and wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5;
provided that R5′ is not —CH2—O—C(O)-(CH2) 14CH3 when R3′ and R4′ are —OH, R2′ is —NH2, and R1′ is —OCH3; and
provided that R5′ is not —CH2—O—C(O)-(CH2)pCH3, wherein p is selected from the group consisting of 10, 12, 14, or 16, when R3′ is identical to R5′, R4′ is —OH, R2′ is —NH2, and R1′ is —OCH3.

### Claim 3 (depends on 2)

The compound of claim 2, wherein R2 and R2′ are independently selected from the group consisting of hydrogen, —NH2, —N+(CH3)3, and —NH—C (N+H2) —NH2—.

### Claim 4 (depends on 3)

The compound of claim 3, wherein R3, R3′, R4, R4′, R5, and R5′ are independently selected from the group consisting of hydrogen, —OH, —O—C(O)-alkyl, —O— alkyl, -alkyl, and —(CH2)—OH.

### Claim 5 (depends on 4)

The compound of claim 4, wherein R1 and R1′ are independently selected from the group consisting of hydrogen, —OCH3, -alkyl, —O— alkyl, —O—C (O) -alkyl, —O—CH2—CH2 (alkyl) —CH2 (alkyl), —O—CH2—CH2 (O-alkyl) —CH2 (O-alkyl), —O—CH2—CH2 (O—C (O) -alkyl) —CH2 (O—C (O) -alkyl), —O—(CH2)m-cholesterol, —O—(CH2),—NH2, and —O—(CH2)n—N+(CH3)3, wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5.

### Claim 6 (depends on 5)

The compound of claim 5, wherein said alkyl moiety is a straight chain hydrocarbon moiety having 14, 16, or 18 carbon atoms and 0, 1, 2, or 3 unsaturations.

### Claim 7 (depends on 6)

The compound of claim 6 having the structure set forth in formula (II):
15

### Claim 8 (depends on 6)

The compound of claim 6 having the structure set forth in formula (III):
16

### Claim 9 (depends on 6)

The compound of claim 6 having the structure set forth in formula (IV):
17

### Claim 10

A composition for delivery one or more macromolecules into one or more cells, comprising:
(a) a compound comprising a glycosyl moiety having a nitrogen-based substituent linked to a carbon atom within said glycosyl moiety, wherein said nitrogen-based substituent is selected from the group consisting of —NH2, —N+(CH3)3, —(CH2)n—N (R10)3, and —NH—C (N+H2) —NH2, and wherein substituents linked to other carbon atoms within said glycosyl moiety are independently selected from the group consisting of hydrogen, -alkyl, —O— alkyl, —O—C (O) -alkyl, —O—CH2—CH2 (O—C (O) —R6) —CH2 (O—C (O) —R7), —O—CH2—CH2 (OR6) —CH2 (OR7), —O—CH2—CH2 (R6) —CH2 (R7), —O—(CH2)m-cholesterol, polyethylene glycol, —O—(CH2)n—N (R8)3, —NH2, —N+(CH3)3, —(CH2)n—N (R9)3, and —(CH2)—OR10 wherein R6, R7, R8, R9, and R10 are independently selected from the group consisting of hydrogen, methyl, and alkyl, and wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5; and
(b) said macromolecule or macromolecules.

### Claim 11

A composition for delivering one or more macromolecules into one or more cells, comprising:
(a) a compound having a structure set forth in formula (I):
18
wherein R1 and R1′ are independently selected from the group consisting of hydrogen, —OH, —OCH3, -alkyl, —O— alkyl, —O—C(O)-alkyl, —O—CH2—CH2(O—C(O)—R6)—CH2 (O—C (O) —R7), —O—CH2—CH2 (OR6) —CH2 (OR7), —O—CH2—CH2 (R6) —CH2 (R7) , —O—(CH2) m-cholesterol, —O—(CH2)n—N (R8)3, —NH2, —N+(CH3)3, —(CH2)n—N (R9)3, and —(CH2) —R10, wherein R6, R7, R8, R9, and R10 are independently selected from the group consisting of hydrogen, methyl, and alkyl, and wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5;
wherein R2 and R2′ are independently selected from the group consisting of hydrogen, —NH2, —N+(CH3) 3, —(CH2)n—N (R11)3, and —NH—C (N+H2) —NH2, wherein said R11 is selected from the group consisting of hydrogen, methyl, and alkyl; and
wherein R3, R3′, R4, R4′, R5, and R5′ are independently selected from the group consisting of hydrogen, —OH, —OCH3, -alkyl, —O— alkyl, —O—C(O)-alkyl, —O—CH2—CH2 (O—C (O) —R6) —CH2 (O—C (O) —R7), —O—CH2—CH2 (OR6) —CH2 (OR7), —O—CH2—CH2 (R6) —CH2 (R7), —O—(CH2)m-cholesterol, —O—(CH2)n—N(R8)3, —NH2, —N+(CH3)3, —(CH2)n—N (R9)3, and —(CH2)—OR1,o wherein R6, R7, R8, R9, R10 are independently selected from the group consisting of hydrogen, methyl, and alkyl, and wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5; and
(b) said macromolecule or macromolecules.

### Claim 12 (depends on 11)

The composition of claim 11, wherein R2 and R2′ are independently selected from the group consisting of —NH2, —N+(CH3)3, and —NH—C(N+H2)—NH2.

### Claim 13 (depends on 12)

The composition of claim 12, wherein said R3, R3′, R4, R4′, R5, and R5′ are independently selected from the group consisting of hydrogen, —OH, —O—C(O)-alkyl, —O— alkyl, and -alkyl, —(CH2)—OH.

### Claim 14 (depends on 13)

The composition of claim 13, wherein said R1 and R1′ are independently selected from the group consisting of —OCH3, -alkyl, —O— alkyl, —O—C(O)-alkyl, —O—CH2—CH2 (alkyl) —CH2 (alkyl) —O—CH2—CH2 (O-alkyl) —CH2 (O-alkyl), —O—CH2—CH2 (O—C (O) -alkyl) —CH2 (O—C (O) -alkyl), —O—(CH2)m-cholesterol, —O—(CH2),—NH2, and —O—(CH2)n—N+(CH3)3, wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5.

### Claim 15 (depends on 14)

The composition of claim 14, wherein said alkyl moiety is a straight chain hydrocarbon moiety having 14, 16, or 18 carbon atoms and 0, 1, 2, or 3 unsaturations.

### Claim 16 (depends on 15)

The composition of claim 15, wherein said compound has the structure set forth in formula (II):
19

### Claim 17 (depends on 15)

The composition of claim 15, wherein said compound has the structure set forth in formula (III):
20

### Claim 18 (depends on 15)

The composition of claim 15, wherein said compound has the structure set forth in formula (IV):
21

### Claim 19 (depends on 11)

The composition of claim 11, wherein said macromolecule is an anionic molecule.

### Claim 20 (depends on 19)

The composition of claim 19, wherein said anionic molecule is selected from the group consisting of a polynucleotide molecule, a DNA molecule, a RNA molecule, and a nucleotide analog molecule.

### Claim 21 (depends on 20)

The composition of claim 20, wherein said DNA molecule is a plasmid molecule comprising at least one element for polypeptide expression in one or more eukaryotic cells.

### Claim 22 (depends on 21)

The composition of claim 21, wherein said plasmid molecule further comprises a gene encoding IL-2.

### Claim 23 (depends on 11)

The composition of claim 11, further comprising at least one co-lipid.

### Claim 24 (depends on 23)

The composition of claim 23, wherein said co-lipid is DOPE.

### Claim 25 (depends on 23)

The composition of claim 23, wherein said co-lipid is cholesterol.

### Claim 26 (depends on 11)

The composition of claim 11, further comprising a cryoprotectant.

### Claim 27 (depends on 26)

The composition of claim 26, wherein said cryoprotectant is PVP.

### Claim 28 (depends on 11)

The composition of claim 11, wherein said composition is capable of forming liposomes.

### Claim 29 (depends on 11)

The composition of claim 11 having an effective diameter between 100 nanometers and 300 nanometers.

### Claim 30 (depends on 11)

The composition of claim 11 having a −/+ charge ratio selected from the group consisting of 1:0.5, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, and 1:9.

### Claim 31 (depends on 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

A method for delivering macromolecules to cells of a mammal, comprising the step of administering a composition of any one of claims 11-30 to said cells.

### Claim 32 (depends on 31)

The method of claim 31, wherein said composition is administered to said cells in vitro.

### Claim 33 (depends on 31)

The method of claim 31, wherein said composition is administered to said cells in vivo.

### Claim 34 (depends on 31)

The method of claim 31, wherein said administration results in IL-2 expression in said cells.

### Claim 35 (depends on 31)

The method of claim 31, wherein said composition is administered by a technique selected from the group consisting of direct injection to a tissue, parenteral injection, intravenous injection, oral administration, and administration by inhalation.

### Claim 36 (depends on 2)

A method for synthesizing a compound of claim 2, comprising the steps of:
(a) reacting a first reactant of formula (V):
22
with a second reactant,
wherein X1 and X1′ are independently selected from the group consisting of hydrogen, halogen atom, and an activatable moiety; X2 and X3 are independently selected from the group consisting of a protecting moiety, hydrogen, halogen, or any activatable moiety; and X4, X4′, X5, X5′, X6 and X6′ are independently selected from the group consisting of hydrogen, —O—acetyl, —OH, —CH2—O—acetyl, —CH2—OH, and —O— alkyl;
wherein said second reactant is selected from the group consisting of HOCH3, HO-alkyl, HO—C(O)-alkyl, HO—CH2—CH2 (O—C (O)—R6) —CH2 (O—C (O) —R7), HO—CH2—CH2 (OR6) —CH2 (OR7) , HO—CH2—CH2 (R6) —CH2(R7) HO—(CH2)m-cholesterol, and HO—(CH2)n—N(R8)3, wherein R6, R7, R8, and R9are independently selected from the group consisting of hydrogen, methyl, and alkyl, and wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5;
(b) reacting the product of step (a) with a reducing agent; and
(c) purifying said compound of claim 2.

### Claim 37 (depends on 2)

A method for synthesizing a compound of claim 2, comprising the steps of:
(a) reacting a first reactant of formula (V):
23
with a second reactant,
wherein X1 and X1′ are independently selected from the group consisting of hydrogen, —OCH3, -alkyl, —O— alkyl, —O—C(O)-alkyl, —O—CH2—CH2 (O—C (O) —R6) —CH2 (O—C (O) —R7), —O—CH2—CH2 (OR6) —CH2 (OR7) , —O—CH2—CH2 (R6) —CH2 (R7), —O—(CH2)m-cholesterol, —O—(CH2),—N(R8)3, —NH2, —N+(CH3) 3, and —(CH2)n—N(R9)3, wherein R6, R7, R8, and R9are independently selected from the group consisting of hydrogen, methyl, and alkyl, and wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5; and wherein X2 and X3 are independently selected from the group consisting of hydrogen and a protecting group, and X4, X4′, X5, X5, X5′, X6, and X6′ are independently selected from the group consisting of hydrogen, —OH, and —O— alkyl;
wherein said second reactant is selected from the group consisting of ClCH3, Cl-alkyl, Cl—CH2—CH2 (O—C (O) —R6) —CH2 (O—C (O) —R7), Cl—CH2—CH2 (OR6) —CH2 (OR7) , Cl—CH2—CH2 (R6) —CH2 (R7), Cl—(CH2)m-cholesterol, and Cl—(CH2)n—N (R8)3, wherein R6, R7, R8, and R9are independently selected from the group consisting of hydrogen, methyl, and alkyl, and wherein m is selected from the group consisting of 0, 1, 2, 3, 4, and 5, and wherein n is selected from the group consisting of 1, 2, 3, 4, and 5;
(b) reacting the product of step (a) with a reducing agent and a catalyst; and
(c) purifying said compound of claim 2.

### Claim 38 (depends on 36, 37)

The method of claims 36 and 37, wherein said protecting group is an N-phthalimido moiety.

### Claim 39 (depends on 36, 37)

The method of claims 36 and 37, wherein said reducing agent is selected from the group consisting of H2NNH2, H2, and NABH4.

### Claim 40 (depends on 37)

The method of claim 37, wherein said catalyst is palladium.
